combination therapy
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
combination therapy
Jul 8, 2024, 18:50 |
Blog
Tumor Board Tuesday on Durva + TACE for HCC
Tumor Board Tuesday published the following post on X: “Did you know that there are…
Jun 30, 2024, 04:58 |
Blog
Victor Moreno: Botensilimab and balstilimab in treating heavily pre-treated patients with MSS mCRC
Victor Moreno, Director of Clinical Research at START Madrid-FJD, shared a post on LinkedIn: .…
Jun 18, 2024, 02:57 |
Blog
Skoda: clonal evolution of Myeloproliferative Neoplasms
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared on X: “Skoda: clonal…
Jun 14, 2024, 09:30 |
Blog
Upcoming webinar on "Overcoming Resistance" led by Michael Wick - The START Center for Cancer Research
The START Center for Cancer Research shared on LinkedIn: . "Don't miss our…
May 29, 2024, 12:03 |
Insight
Eric Singhi: MARIPOSA a path forward to help us determine who benefits from 1L combination therapy?
Eric Singhi shared on X: "MARIPOSA: Amivantamab + lazertinib v osimertinib in 1L EGFR+ mNSCLC:…
May 25, 2024, 09:12 |
Insight
Sankalp Arora: Excited to be presenting longterm follow up results of AZA + RUX in patients with myelofibrosis at ASCO24
Sankalp Arora, Heme/Onc fellow at MD Anderson Cancer Center, shared on X/Twitter: "The ASCO24 countdown begins!…
May 23, 2024, 09:19 |
Blog
Stephen D. Nimer's recent study could lead to a new combination therapy for leukemia
Sylvester Comprehensive Cancer Center shared a post on X: “Stephen D. Nimer's recent study could lead…
May 14, 2024, 12:51 |
Blog
Vivek Subbiah: About time for precision immunotherapy
Vivek Subbiah shared a post on LinkedIn: “Sharing our editorial: Rationalizing rules for immunotherapy combination trials:…
May 6, 2024, 19:10 |
Blog
Erman Akkus: ASCO Ed book on mNSCLC without oncogenic alterations
Erman Akkus, medical oncologist at Ankara Medical University, shared on Twitter/X: "Metastatic NSCLC without oncogenic…
May 2, 2024, 09:39 |
Insight
Piotr Wysocki: Combination of chemotherapy and endocrine treatment in breast cancer
Piotr Wysocki recently shared on LinkedIn: "Dear Colleagues, I invite you to read a review article…
Apr 9, 2024, 12:53 |
Blog
Christiana Bardon: The AACR industry partnering event was a tremendous success
Christiana Bardon, Co-Managing Partner at MPM BioImpact, shared on their LinkedIn: ''The American Association for…
Feb 19, 2024, 18:18 |
Blog
Anas Younes: We are developing more than one drug for the same disease indication, so we can build future combination regimens
Anas Younes posted on LinkedIn: ''Our hematology team spent the last 3 days reviewing our…
Jan 14, 2024, 14:49 |
Blog
Chris Boshoff: The European Medicines Agency approved our Prostate Cancer combination for men living with metastatic castration-resistant prostate cancer
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared on LinkedIn: "I’m proud…
All:
13
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube